Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (61-70 of 420) with videos related to

Pageof 42
Sort By:
Cold Spring Harbor Perspectives in Biology|July 1, 2017
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin StemSarah F Andrews, Barney S Graham, John R Mascola, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 20, 2019
OMIP-061: 20-Color Flow Cytometry Panel for High-Dimensional Characterization of Murine Antigen-Presenting CellsAnthony T DiPiazza, Juliane P Hill, Barney S Graham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challengeTeresa R Johnson, Robert A Parker, Joyce E Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Modified vaccinia Ankara: potential as an alternative smallpox vaccineLewis H McCurdy, Brenda D Larkin, Julie E Martin, et al.
Journal of Virology|May 14, 2004
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSVTeresa R Johnson, Michael N Teng, Peter L Collins, et al.
Virology|February 6, 2007
Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infectionJohn A Rutigliano, Tracy J Ruckwardt, Julie E Martin, et al.
Nature Reviews. Microbiology|April 17, 2009
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNancy J Sullivan, Julie E Martin, Barney S Graham, et al.
Journal of Virology|July 29, 2004
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSVTeresa R Johnson, Steven M Varga, Thomas J Braciale, et al.
Journal of Virology|April 5, 2002
NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virusTeresa R Johnson, Seokmann Hong, Luc Van Kaer, et al.
Journal of Virology|March 7, 2009
Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine modelJie Liu, Tracy J Ruckwardt, Man Chen, et al.
Pageof 42

Showing results (61-70 of 420) with videos related to

Sort By:
Pageof 42
Cold Spring Harbor Perspectives in Biology|July 1, 2017
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin StemSarah F Andrews, Barney S Graham, John R Mascola, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 20, 2019
OMIP-061: 20-Color Flow Cytometry Panel for High-Dimensional Characterization of Murine Antigen-Presenting CellsAnthony T DiPiazza, Juliane P Hill, Barney S Graham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challengeTeresa R Johnson, Robert A Parker, Joyce E Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Modified vaccinia Ankara: potential as an alternative smallpox vaccineLewis H McCurdy, Brenda D Larkin, Julie E Martin, et al.
Journal of Virology|May 14, 2004
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSVTeresa R Johnson, Michael N Teng, Peter L Collins, et al.
Virology|February 6, 2007
Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infectionJohn A Rutigliano, Tracy J Ruckwardt, Julie E Martin, et al.
Nature Reviews. Microbiology|April 17, 2009
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNancy J Sullivan, Julie E Martin, Barney S Graham, et al.
Journal of Virology|July 29, 2004
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSVTeresa R Johnson, Steven M Varga, Thomas J Braciale, et al.
Journal of Virology|April 5, 2002
NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virusTeresa R Johnson, Seokmann Hong, Luc Van Kaer, et al.
Journal of Virology|March 7, 2009
Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine modelJie Liu, Tracy J Ruckwardt, Man Chen, et al.
Pageof 42